1	Human	_	JJ	_	_	6	NMOD	_	_
2	neuron-committed	_	JJ	_	_	6	NMOD	_	_
3	teratocarcinoma	_	NN	_	_	6	NMOD	_	_
4	NT2	_	NN	_	_	6	NMOD	_	_
5	cell	_	NN	_	_	6	NMOD	_	_
6	line	_	NN	_	_	7	VMOD	_	_
7	has	_	VBZ	_	_	0	ROOT	_	_
8	abnormal	_	JJ	_	_	10	NMOD	_	_
9	ND10	_	NN	_	_	10	NMOD	_	_
10	structures	_	NNS	_	_	7	VMOD	_	_
11	and	_	CC	_	_	7	COORD	_	_
12	is	_	VBZ	_	_	11	CONJ	_	_
13	poorly	_	RB	_	_	12	VMOD	_	_
14	infected	_	VBN	_	_	12	VC	_	_
15	by	_	IN	_	_	14	VMOD	_	_
16	herpes	_	NN	_	_	19	NMOD	_	_
17	simplex	_	NN	_	_	19	NMOD	_	_
18	virus	_	NN	_	_	19	NMOD	_	_
19	type	_	NN	_	_	15	PMOD	_	_
20	1	_	CD	_	_	19	NMOD	_	_
21	.	_	.	_	_	7	P	_	_
		
1	Herpes	_	NN	_	_	4	NMOD	_	_
2	simplex	_	NN	_	_	4	NMOD	_	_
3	virus	_	NN	_	_	4	NMOD	_	_
4	type	_	NN	_	_	12	NMOD	_	_
5	1	_	CD	_	_	4	NMOD	_	_
6	(	_	(	_	_	7	P	_	_
7	HSV-1	_	NN	_	_	4	PRN	_	_
8	)	_	)	_	_	7	P	_	_
9	immediate-early	_	JJ	_	_	12	NMOD	_	_
10	regulatory	_	JJ	_	_	12	NMOD	_	_
11	protein	_	NN	_	_	12	NMOD	_	_
12	ICP0	_	NN	_	_	13	VMOD	_	_
13	stimulates	_	VBZ	_	_	0	ROOT	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	initiation	_	NN	_	_	13	VMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	lytic	_	JJ	_	_	18	NMOD	_	_
18	infection	_	NN	_	_	16	PMOD	_	_
19	and	_	CC	_	_	18	COORD	_	_
20	reactivation	_	NN	_	_	19	CONJ	_	_
21	from	_	IN	_	_	20	NMOD	_	_
22	quiescence	_	NN	_	_	21	PMOD	_	_
23	in	_	IN	_	_	20	NMOD	_	_
24	human	_	JJ	_	_	26	NMOD	_	_
25	fibroblast	_	NN	_	_	26	NMOD	_	_
26	cells	_	NNS	_	_	23	PMOD	_	_
27	.	_	.	_	_	13	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	functions	_	NNS	_	_	3	VMOD	_	_
3	correlate	_	VBP	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	its	_	PRP$	_	_	6	NMOD	_	_
6	ability	_	NN	_	_	4	PMOD	_	_
7	to	_	TO	_	_	6	NMOD	_	_
8	localize	_	VB	_	_	7	IM	_	_
9	to	_	TO	_	_	8	VMOD	_	_
10	and	_	CC	_	_	8	COORD	_	_
11	disrupt	_	VBP	_	_	10	CONJ	_	_
12	centromeres	_	NNS	_	_	11	VMOD	_	_
13	and	_	CC	_	_	12	COORD	_	_
14	specific	_	JJ	_	_	16	NMOD	_	_
15	subnuclear	_	JJ	_	_	16	NMOD	_	_
16	structures	_	NNS	_	_	13	CONJ	_	_
17	known	_	VBN	_	_	12	APPO	_	_
18	as	_	IN	_	_	17	VMOD	_	_
19	ND10	_	NN	_	_	18	PMOD	_	_
20	,	_	,	_	_	19	P	_	_
21	PML	_	NN	_	_	23	NMOD	_	_
22	nuclear	_	JJ	_	_	23	NMOD	_	_
23	bodies	_	NNS	_	_	19	COORD	_	_
24	,	_	,	_	_	23	P	_	_
25	or	_	CC	_	_	23	COORD	_	_
26	promyelocytic	_	JJ	_	_	28	NMOD	_	_
27	oncogenic	_	JJ	_	_	28	NMOD	_	_
28	domains	_	NNS	_	_	25	CONJ	_	_
29	.	_	.	_	_	3	P	_	_
		
1	Since	_	IN	_	_	13	VMOD	_	_
2	the	_	DT	_	_	4	NMOD	_	_
3	natural	_	JJ	_	_	4	NMOD	_	_
4	site	_	NN	_	_	8	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	herpesvirus	_	NN	_	_	7	NMOD	_	_
7	latency	_	NN	_	_	5	PMOD	_	_
8	is	_	VBZ	_	_	1	SUB	_	_
9	in	_	IN	_	_	8	VMOD	_	_
10	neurons	_	NNS	_	_	9	PMOD	_	_
11	,	_	,	_	_	13	P	_	_
12	we	_	PRP	_	_	13	VMOD	_	_
13	investigated	_	VBD	_	_	0	ROOT	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	status	_	NN	_	_	13	VMOD	_	_
16	of	_	IN	_	_	15	NMOD	_	_
17	ND10	_	NN	_	_	16	PMOD	_	_
18	and	_	CC	_	_	17	COORD	_	_
19	centromeres	_	NNS	_	_	18	CONJ	_	_
20	in	_	IN	_	_	15	NMOD	_	_
21	uninfected	_	JJ	_	_	25	NMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	infected	_	JJ	_	_	22	CONJ	_	_
24	human	_	JJ	_	_	25	NMOD	_	_
25	cells	_	NNS	_	_	20	PMOD	_	_
26	with	_	IN	_	_	25	NMOD	_	_
27	neuronal	_	JJ	_	_	28	NMOD	_	_
28	characteristics	_	NNS	_	_	26	PMOD	_	_
29	.	_	.	_	_	13	P	_	_
		
1	We	_	PRP	_	_	2	VMOD	_	_
2	found	_	VBD	_	_	0	ROOT	_	_
3	that	_	IN	_	_	2	VMOD	_	_
4	NT2	_	NN	_	_	5	NMOD	_	_
5	cells	_	NNS	_	_	15	VMOD	_	_
6	,	_	,	_	_	5	P	_	_
7	a	_	DT	_	_	13	NMOD	_	_
8	neuronally	_	RB	_	_	9	AMOD	_	_
9	committed	_	VBN	_	_	13	NMOD	_	_
10	human	_	JJ	_	_	13	NMOD	_	_
11	teratocarcinoma	_	NN	_	_	13	NMOD	_	_
12	cell	_	NN	_	_	13	NMOD	_	_
13	line	_	NN	_	_	5	APPO	_	_
14	,	_	,	_	_	5	P	_	_
15	have	_	VBP	_	_	3	SUB	_	_
16	abnormal	_	JJ	_	_	17	NMOD	_	_
17	ND10	_	NN	_	_	15	VMOD	_	_
18	characterized	_	VBN	_	_	17	APPO	_	_
19	by	_	IN	_	_	18	VMOD	_	_
20	low	_	JJ	_	_	21	NMOD	_	_
21	expression	_	NN	_	_	19	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	the	_	DT	_	_	27	NMOD	_	_
24	major	_	JJ	_	_	27	NMOD	_	_
25	ND10	_	NN	_	_	27	NMOD	_	_
26	component	_	NN	_	_	27	NMOD	_	_
27	PML	_	NN	_	_	22	PMOD	_	_
28	and	_	CC	_	_	27	COORD	_	_
29	no	_	DT	_	_	31	NMOD	_	_
30	detectable	_	JJ	_	_	31	NMOD	_	_
31	expression	_	NN	_	_	28	CONJ	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	another	_	DT	_	_	36	NMOD	_	_
34	major	_	JJ	_	_	36	NMOD	_	_
35	ND10	_	NN	_	_	36	NMOD	_	_
36	antigen	_	NN	_	_	32	PMOD	_	_
37	,	_	,	_	_	31	P	_	_
38	Sp100	_	NN	_	_	31	COORD	_	_
39	.	_	.	_	_	2	P	_	_
		
1	In	_	IN	_	_	5	VMOD	_	_
2	addition	_	NN	_	_	1	PMOD	_	_
3	,	_	,	_	_	5	P	_	_
4	PML	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	less	_	RBR	_	_	7	AMOD	_	_
7	extensively	_	RB	_	_	5	VMOD	_	_
8	modified	_	VBN	_	_	5	VC	_	_
9	by	_	IN	_	_	8	VMOD	_	_
10	the	_	DT	_	_	13	NMOD	_	_
11	ubiquitin-like	_	JJ	_	_	13	NMOD	_	_
12	protein	_	NN	_	_	13	NMOD	_	_
13	SUMO-1	_	NN	_	_	9	PMOD	_	_
14	in	_	IN	_	_	13	NMOD	_	_
15	NT2	_	NN	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	14	PMOD	_	_
17	compared	_	VBN	_	_	13	NMOD	_	_
18	to	_	TO	_	_	17	PMOD	_	_
19	fibroblasts	_	NNS	_	_	18	PMOD	_	_
20	.	_	.	_	_	5	P	_	_
		
1	After	_	IN	_	_	9	VMOD	_	_
2	treatment	_	NN	_	_	1	PMOD	_	_
3	with	_	IN	_	_	2	NMOD	_	_
4	retinoic	_	JJ	_	_	5	NMOD	_	_
5	acid	_	NN	_	_	3	PMOD	_	_
6	,	_	,	_	_	9	P	_	_
7	NT2	_	NN	_	_	8	NMOD	_	_
8	cells	_	NNS	_	_	9	VMOD	_	_
9	differentiate	_	VBP	_	_	0	ROOT	_	_
10	into	_	IN	_	_	9	VMOD	_	_
11	neuron-like	_	JJ	_	_	13	NMOD	_	_
12	hNT	_	JJ	_	_	13	NMOD	_	_
13	cells	_	NNS	_	_	10	PMOD	_	_
14	which	_	WDT	_	_	15	VMOD	_	_
15	express	_	VBP	_	_	13	NMOD	_	_
16	very	_	RB	_	_	17	AMOD	_	_
17	high	_	JJ	_	_	18	NMOD	_	_
18	levels	_	NNS	_	_	15	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	both	_	CC	_	_	21	DEP	_	_
21	PML	_	NN	_	_	19	PMOD	_	_
22	and	_	CC	_	_	21	COORD	_	_
23	Sp100	_	NN	_	_	22	CONJ	_	_
24	.	_	.	_	_	9	P	_	_
		
1	Infection	_	NN	_	_	10	VMOD	_	_
2	of	_	IN	_	_	1	NMOD	_	_
3	both	_	CC	_	_	4	DEP	_	_
4	NT2	_	JJ	_	_	7	NMOD	_	_
5	and	_	CC	_	_	4	COORD	_	_
6	hNT	_	JJ	_	_	5	CONJ	_	_
7	cells	_	NNS	_	_	2	PMOD	_	_
8	by	_	IN	_	_	1	NMOD	_	_
9	HSV-1	_	NN	_	_	8	PMOD	_	_
10	was	_	VBD	_	_	0	ROOT	_	_
11	poor	_	JJ	_	_	10	VMOD	_	_
12	compared	_	VBN	_	_	11	AMOD	_	_
13	to	_	TO	_	_	12	PMOD	_	_
14	human	_	JJ	_	_	15	NMOD	_	_
15	fibroblasts	_	NNS	_	_	13	PMOD	_	_
16	,	_	,	_	_	10	P	_	_
17	and	_	CC	_	_	10	COORD	_	_
18	after	_	IN	_	_	10	VMOD	_	_
19	low-multiplicity	_	NN	_	_	21	NMOD	_	_
20	infection	_	NN	_	_	21	NMOD	_	_
21	yields	_	NNS	_	_	18	PMOD	_	_
22	of	_	IN	_	_	21	NMOD	_	_
23	virus	_	NN	_	_	22	PMOD	_	_
24	were	_	VBD	_	_	17	CONJ	_	_
25	reduced	_	VBN	_	_	24	VC	_	_
26	by	_	IN	_	_	25	VMOD	_	_
27	2	_	CD	_	_	29	DEP	_	_
28	to	_	TO	_	_	29	DEP	_	_
29	3	_	CD	_	_	30	NMOD	_	_
30	orders	_	NNS	_	_	26	PMOD	_	_
31	of	_	IN	_	_	30	NMOD	_	_
32	magnitude	_	NN	_	_	31	PMOD	_	_
33	.	_	.	_	_	10	P	_	_
		
1	ICP0-deficient	_	NN	_	_	2	NMOD	_	_
2	mutants	_	NNS	_	_	3	VMOD	_	_
3	were	_	VBD	_	_	0	ROOT	_	_
4	also	_	RB	_	_	3	VMOD	_	_
5	disabled	_	VBN	_	_	3	VC	_	_
6	in	_	IN	_	_	5	VMOD	_	_
7	the	_	DT	_	_	10	NMOD	_	_
8	neuron-related	_	JJ	_	_	10	NMOD	_	_
9	cell	_	NN	_	_	10	NMOD	_	_
10	lines	_	NNS	_	_	6	PMOD	_	_
11	,	_	,	_	_	3	P	_	_
12	and	_	CC	_	_	3	COORD	_	_
13	cells	_	NNS	_	_	20	VMOD	_	_
14	quiescently	_	RB	_	_	15	VMOD	_	_
15	infected	_	VBN	_	_	13	APPO	_	_
16	with	_	IN	_	_	15	VMOD	_	_
17	an	_	DT	_	_	19	NMOD	_	_
18	ICP0-null	_	JJ	_	_	19	NMOD	_	_
19	virus	_	NN	_	_	16	PMOD	_	_
20	could	_	MD	_	_	12	CONJ	_	_
21	be	_	VB	_	_	20	VC	_	_
22	established	_	VBN	_	_	21	VC	_	_
23	.	_	.	_	_	3	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	correlated	_	VBD	_	_	0	ROOT	_	_
4	with	_	IN	_	_	3	VMOD	_	_
5	less-efficient	_	JJ	_	_	6	NMOD	_	_
6	disruption	_	NN	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	ND10	_	NN	_	_	7	PMOD	_	_
9	and	_	CC	_	_	8	COORD	_	_
10	centromeres	_	NNS	_	_	9	CONJ	_	_
11	induced	_	VBN	_	_	8	APPO	_	_
12	by	_	IN	_	_	11	VMOD	_	_
13	ICP0	_	NN	_	_	12	PMOD	_	_
14	in	_	IN	_	_	13	NMOD	_	_
15	NT2	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	hNT	_	JJ	_	_	18	NMOD	_	_
18	cells	_	NNS	_	_	16	CONJ	_	_
19	.	_	.	_	_	3	P	_	_
		
1	Furthermore	_	RB	_	_	17	VMOD	_	_
2	,	_	,	_	_	17	P	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	ability	_	NN	_	_	17	VMOD	_	_
5	of	_	IN	_	_	4	NMOD	_	_
6	ICP0	_	NN	_	_	5	PMOD	_	_
7	to	_	TO	_	_	4	NMOD	_	_
8	activate	_	VB	_	_	7	IM	_	_
9	gene	_	NN	_	_	10	NMOD	_	_
10	expression	_	NN	_	_	8	VMOD	_	_
11	in	_	IN	_	_	10	NMOD	_	_
12	transfection	_	NN	_	_	13	NMOD	_	_
13	assays	_	NNS	_	_	11	PMOD	_	_
14	in	_	IN	_	_	10	NMOD	_	_
15	NT2	_	NN	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	14	PMOD	_	_
17	was	_	VBD	_	_	0	ROOT	_	_
18	poor	_	JJ	_	_	17	VMOD	_	_
19	compared	_	VBN	_	_	18	AMOD	_	_
20	to	_	TO	_	_	19	PMOD	_	_
21	Vero	_	NN	_	_	22	NMOD	_	_
22	cells	_	NNS	_	_	20	PMOD	_	_
23	.	_	.	_	_	17	P	_	_
		
1	These	_	DT	_	_	2	NMOD	_	_
2	results	_	NNS	_	_	3	VMOD	_	_
3	suggest	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	a	_	DT	_	_	7	NMOD	_	_
6	contributory	_	JJ	_	_	7	NMOD	_	_
7	factor	_	NN	_	_	17	VMOD	_	_
8	in	_	IN	_	_	7	NMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	reduced	_	VBN	_	_	12	NMOD	_	_
11	HSV-1	_	NN	_	_	12	NMOD	_	_
12	replication	_	NN	_	_	8	PMOD	_	_
13	in	_	IN	_	_	12	NMOD	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	neuron-related	_	JJ	_	_	16	NMOD	_	_
16	cells	_	NNS	_	_	13	PMOD	_	_
17	is	_	VBZ	_	_	4	SUB	_	_
18	inefficient	_	JJ	_	_	20	NMOD	_	_
19	ICP0	_	NN	_	_	20	NMOD	_	_
20	function	_	NN	_	_	17	VMOD	_	_
21	;	_	:	_	_	17	P	_	_
22	it	_	PRP	_	_	23	VMOD	_	_
23	is	_	VBZ	_	_	17	COORD	_	_
24	possible	_	JJ	_	_	23	VMOD	_	_
25	that	_	IN	_	_	23	VMOD	_	_
26	this	_	DT	_	_	27	VMOD	_	_
27	is	_	VBZ	_	_	25	SUB	_	_
28	pertinent	_	JJ	_	_	27	VMOD	_	_
29	to	_	TO	_	_	28	AMOD	_	_
30	the	_	DT	_	_	31	NMOD	_	_
31	establishment	_	NN	_	_	29	PMOD	_	_
32	of	_	IN	_	_	31	NMOD	_	_
33	latent	_	JJ	_	_	34	NMOD	_	_
34	infection	_	NN	_	_	32	PMOD	_	_
35	in	_	IN	_	_	34	NMOD	_	_
36	neurons	_	NNS	_	_	35	PMOD	_	_
37	in	_	FW	_	_	34	NMOD	_	_
38	vivo	_	FW	_	_	37	AMOD	_	_
39	.	_	.	_	_	3	P	_	_
		
